SCHEMBL23476142

SCHEMBL23476142

COc1ccc(Cl)c(N2Cc3cnc(Nc4ccc(N)c(C)c4)nc3NC2=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.47
CSF1R P07333 4/20 0.47
EIF2AK4 Q9P2K8 1/20 0.46
FGFR4 P22455 3/20 0.45
PDGFRB P09619 1/20 0.45
KIT P10721 1/20 0.45
FGFR1 P11362 1/20 0.45
PDGFRA P16234 1/20 0.45
FGFR2 P21802 1/20 0.45
FGFR3 P22607 1/20 0.45
FLT3 P36888 1/20 0.45
PLK1 P53350 7/20 0.44
KDR P35968 5/20 0.44
MAPK14 Q16539 1/20 0.42
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.41
JAK1 P23458 2/20 0.40
TYK2 P29597 2/20 0.40
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23482820 0.81 EGFR (0.52) EGFRCSF1RFGFR4PDGFRBKIT
SCHEMBL25866203 0.74 EGFR (0.46) EGFRCSF1RFGFR4PDGFRBKIT
SCHEMBL3970864 0.74 FGFR1 (0.49) FGFR4FGFR1FGFR2FGFR3PLK1
SCHEMBL5768493 0.72 FGFR4 (0.57) EGFRFGFR4PDGFRBFGFR1PDGFRA
SCHEMBL3975110 0.71 FGFR4 (0.61) EGFRFGFR4PDGFRBFGFR1PDGFRA
SCHEMBL3972049 0.71 LCK (0.53) EGFRCSF1RFGFR4PDGFRBFGFR1
SCHEMBL24490202 0.69 FGFR4 (0.56) FGFR4FGFR1FGFR2FGFR3FLT3
SCHEMBL3972648 0.69 FGFR4 (0.57) FGFR4FGFR1FGFR2FGFR3KDR
SCHEMBL3967389 0.68 LCK (0.54) EGFRCSF1RFGFR4PDGFRBFGFR1
SCHEMBL3971330 0.67 LCK (0.56) EGFRCSF1RFGFR4PDGFRBFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021113651-A2 DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY Ashvattha Therapeutics, Inc. (US) 2021-06-10 WO disclosed
WO-2021113657-A1 TRIANTENNARY N-ACETYLGALACTOSAMINE MODIFIED HYDROXYL POLYAMIDOAMINE DENDRIMERS AND METHODS OF USE THEREOF Ashvattha Therapeutics, Inc. (US) 2021-06-10 WO disclosed